Company research
Sintx Technologies, Inc.
CIK 1269026Updated Sep 24, 2026
SecuritySINT · NASDAQ · equity
Historical securities (1)
AMDDW · NASDAQ · warrant · closed May 15, 2023Name history
AMEDICA CORP · through Oct 5, 2018AMEDICA Corp · through Oct 5, 2018
SINT price & chart
Loading TradingView…
NASDAQ:SINT on TradingView ↗About the company
Headquartered in Salt Lake City, Utah, SINTX Technologies, Inc. (NASDAQ: SINT) is an advanced ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. SINTX’s technologies are supported by peer-reviewed research, a patent portfolio, U.S.-based manufacturing capabilities, and strategic industry relationships. The Company’s business includes proprietary biomaterials and medical device technologies, as well as contract manufacturing and other advanced ceramics opportunities. SINTX’s product portfolio includes the FDA-cleared SINAPTIC Foot & Ankle Implant System for reconstructive surgery.
In the news
SINTX Technologies Engages Veteran MedTech Executive Chris Lyons and Southern Metrics to Establish Strategic Opportunity Management Program ↗
Recent filings
EFFECT filing
SCHEDULE 13G filing
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
S-3 filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
Show 5 more recent filings
10-Q filing
Regulation FD Disclosure
Items 7.01, 9.01
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities
Items 1.01, 3.02, 9.01
EFFECT filing
S-3 filing
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 9,506,000Source | 9,413,000Source | 15,365,000Source | 15,773,000Source |
| Property, Plant and Equipment, NetUSD | 476,000Source | 922,000Source | 4,826,000Source | 5,691,000Source |
| GoodwillUSD | 302,000Source | — | — | — |
| Intangible Assets, Net (Excluding Goodwill)USD | 142,000Source | 16,000Source | 21,000Source | 26,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 4,140,000Source | 3,598,000Source | 3,340,000Source | 6,245,000Source |
| Inventory, NetUSD | 825,000Source | 502,000Source | 1,221,000Source | 737,000Source |
| Assets, CurrentUSD | 5,650,000Source | 4,771,000Source | 5,532,000Source | 7,209,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 507,000Source | 465,000Source | 539,000Source | 344,000Source |
| Operating Lease, Right-of-Use AssetUSD | 2,458,000Source | 3,159,000Source | 4,094,000Source | 2,309,000Source |
| Other Assets, NoncurrentUSD | 259,000Source | 80,000Source | 559,000Source | 85,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 6,577,000Source | 5,519,000Source | 6,593,000Source | 10,069,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 40,000Source | 13,000Source | 53,000Source | 5,000Source |
| Additional Paid in CapitalUSD | 295,124,000Source | 285,619,000Source | 279,433,000Source | 268,154,000Source |
| Retained Earnings (Accumulated Deficit)USD | -292,102,000Source | -281,738,000Source | -270,714,000Source | -262,455,000Source |
| Stockholders' Equity Attributable to ParentUSD | 2,929,000Source | 3,894,000Source | 8,772,000Source | 5,704,000Source |
| Liabilities and EquityUSD | 9,506,000Source | 9,413,000Source | 15,365,000Source | 15,773,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 3,733,000Source | 1,982,000Source | 2,906,000Source | 8,078,000Source |
| Operating Lease, Liability, CurrentUSD | 398,000Source | 456,000Source | 512,000Source | 738,000Source |
| Accounts Payable, CurrentUSD | 382,000Source | 299,000Source | 636,000Source | 434,000Source |
| Operating Lease, Liability, NoncurrentUSD | 2,844,000Source | 3,537,000Source | 3,687,000Source | 1,621,000Source |
| Other Liabilities, NoncurrentUSD | — | — | — | 2,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 422,000Source | 986,000Source | 1,404,000Source | 1,618,000Source |
| Long-term Debt, Current MaturitiesUSD | 7,000Source | 32,000Source | 46,000Source | 160,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | — | — | — | 368,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 1,390,000Source | 82,000Source | 291,000Source | 369,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in InventoriesUSD | 85,000Source | -72,000Source | 485,000Source | 140,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -8,571,000Source | -8,642,000Source | -14,115,000Source | -10,263,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 913,000Source | -194,000Source | -501,000Source | -1,101,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 185,000Source | 690,000Source | 530,000Source | 1,405,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 133,000Source | — | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 8,200,000Source | 9,094,000Source | 11,711,000Source | 3,336,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 542,000Source | 258,000Source | -2,905,000Source | -8,028,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 52,000Source | 29,000Source | 21,000Source | 1,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 19,000Source | 5,000Source | 5,000Source | 5,000Source |
| DepreciationUSD | 319,000Source | 842,000Source | 907,000Source | 335,000Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | -124,000Source | 3,475,000Source | 5,610,000Source | -1,091,000Source |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | 327,000Source | -19,000Source | 17,000Source | -1,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | 352,000Source | -18,000Source | 17,000Source | -1,000Source |
| General and Administrative ExpenseUSD | 6,197,000Source | 3,997,000Source | 4,222,000Source | 3,990,000Source |
| GoodwillUSD | 302,000Source | — | — | — |
| Impairment of Intangible Assets, Finite-livedUSD | — | — | — | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -10,364,000Source | -11,024,000Source | -8,259,000Source | -12,039,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -17,083,000Source | -11,024,000Source | -8,285,000Source | -16,489,000Source |
| Nonoperating Income (Expense)USD | 357,000Source | 3,023,000Source | 5,099,000Source | -704,000Source |
| Operating ExpensesUSD | 11,182,000Source | 16,123,000Source | 15,201,000Source | 12,631,000Source |
| Other Nonoperating Income (Expense)USD | 31,000Source | 39,000Source | 17,000Source | 382,000Source |
| Proceeds from Issuance of Common StockUSD | 4,380,000Source | 6,075,000Source | 5,177,000Source | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 1,018,000Source | 2,887,000Source | 2,627,000Source | 1,561,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Operating Income (Loss)USD | -10,721,000Source | -14,047,000Source | -13,358,000Source | -11,335,000Source |
| Other Nonoperating Income (Expense)USD | 31,000Source | 39,000Source | 17,000Source | 382,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -10,364,000Source | -11,024,000Source | -8,259,000Source | -12,039,000Source |
| Net Income (Loss) Attributable to ParentUSD | -10,364,000Source | -11,024,000Source | -8,259,000Source | -12,039,000Source |
| Earnings Per Share, BasicUSD per share | -6.16Source | -14.87Source | -2.22Source | -54.67Source |
| Earnings Per Share, DilutedUSD per share | -6.16Source | -15.19Source | -3.13Source | -60.81Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 2,773,518Source | 741,250Source | 3,736,412Source | 301,610Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 2,773,518Source | 744,782Source | 4,357,242Source | 317,323Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 19,000Source | 5,000Source | 5,000Source | 5,000Source |
| General and Administrative ExpenseUSD | 6,197,000Source | 3,997,000Source | 4,222,000Source | 3,990,000Source |
| Gross ProfitUSD | 461,000Source | 2,076,000Source | 1,843,000Source | 1,296,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | -3.74Source | -14.87Source | -2.21Source | — |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | -3.74Source | -15.19Source | -3.12Source | — |
| Interest Income, OtherUSD | 175,000Source | 107,000Source | 135,000Source | 23,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -17,083,000Source | -11,024,000Source | -8,285,000Source | -16,489,000Source |
| Nonoperating Income (Expense)USD | 357,000Source | 3,023,000Source | 5,099,000Source | -704,000Source |
| Operating ExpensesUSD | 11,182,000Source | 16,123,000Source | 15,201,000Source | 12,631,000Source |
| Preferred Stock Dividends, Income Statement ImpactUSD | — | — | 26,000Source | 4,450,000Source |
| Research and Development ExpenseUSD | 4,587,000Source | 5,201,000Source | 8,713,000Source | 6,450,000Source |
| Selling and Marketing ExpenseUSD | 242,000Source | 614,000Source | 1,137,000Source | 1,336,000Source |
Filing attachments
ex99-1.htm · 8-K · 2026-08-13
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 SINTX Technologies Regains Compliance with Nasdaq Stockholders’ Equity Requirement SALT LAKE CITY, Utah - August 13, 2026 - SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a company focused on advanced silicon nitride materials and medical technologies, today announced that it received written notification from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained com…
Read attachment ↗ex99-1.htm · 8-K · 2026-08-11
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives SALT LAKE CITY, Utah - August 11, 2026 - SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced silicon nitride biomaterials and ceramics for medical and industrial applications, today provided a business update in conjunction with the filing of its Quarterly R…
Read attachment ↗ex99-1.htm · 8-K · 2026-07-23
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 SINTX Technologies Engages Veteran MedTech Executive Chris Lyons and Southern Metrics to Establish Strategic Opportunity Management Program SALT LAKE CITY, Utah - July 23, 2026 - SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced biomaterials and silicon nitride technologies for medical device and industrial applications, today announced that it has engaged Southern Metrics Consulting (“Southern Metrics”) to a…
Read attachment ↗ex4-1.htm · 8-K · 2026-07-02
EX-4.1 2 ex4-1.htm EX-4.1 Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE …
Read attachment ↗ex4-2.htm · 8-K · 2026-07-02
EX-4.2 3 ex4-2.htm EX-4.2 Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE …
Read attachment ↗ex4-1.htm · 8-K · 2026-06-03
EX-4.1 2 ex4-1.htm EX-4.1 Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE …
Read attachment ↗